IRCT2016010312782N9已完成3 期
Methotrexate alone vs. Methotrexate plus Betamethasone in the Treatment of Plaque-type Psoriasis
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15 years 至 65 years（—）
- 性别
- All
入选标准
- •Patients with Plaue type of Psoriasis with involvement above 10% of body; Age range15-65; No sensitivity to Methotrexate; No contraindication for Betamethasone use; No comorbidity with other Autoimmune diseases.
- •Exclusion criteria: Patients resume from participation in the study; Impossibility of follow up of the patient due to various reason; Use of other treatment method during the study; Receive of other drugs during the study; Occurrence of drugs adverse reactions.
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
A Clinical trial to compare the effect of methotrexate alone and the effect of giving methotrexate along with atorvastatin for the treatment of psoriasis vulgarisCTRI/2018/10/016101SRM MEDICAL COLLEGE HOSPITAL AND RESEARCH CENTRE
进行中（未招募）
1 期
Methotrexate and leflunomide combination therapy in psoriatic arthritis.Adults diagnosed with Psoriatic ArthritisEUCTR2018-002362-39-NLSt Maartenskliniek78
已完成
4 期
Comparing Methotrexate monotherapy with methotrexate Plus LEflunomide combination ThErapy in Psoriatic Arthritis: A pragmatic randomized placebo-controlled double-blind clinical trial.NL-OMON46222Sint Maartenskliniek78
已完成
不适用
Methotrexate and leflunomide combination therapy in psoriatic arthritisPsoriatic arthritis Artritis psoriaticaNL-OMON21424St Maartenskliniek, Nijmegen78
尚未招募
Unknown
Comparing methotrexate and methotrexate with methotrexate with apremilast in modifying biochemical parameters of psoriasis patients.CTRI/2023/03/050882Anisha Biswal